Design to come?

WP_Post Object
(
    [ID] => 2520
    [post_author] => 3
    [post_date] => 2025-05-29 15:55:25
    [post_date_gmt] => 2025-05-29 20:55:25
    [post_content] => 
    [post_title] => Intensity Therapeutics, Inc.'s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
    [post_excerpt] => 
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => intensity-therapeutics-inc-s-phase-3-invincible-3-sarcoma-study-selected-for-presentation-at-the-american-society-of-clinical-oncology-asco-2025-annual-meeting
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2025-05-29 15:55:25
    [post_modified_gmt] => 2025-05-29 20:55:25
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://vcapital.com/?post_type=news&p=2520
    [menu_order] => 0
    [post_type] => news
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
)